With over 60 percent of acute stroke survivors being left unable to walk or needing intervention to walk, the demand for a sustainable product to aid in the rehabilitation process has steadily increased
New York, NY (PRWEB) May 27, 2016
With over 60 percent of acute stroke survivors being left unable to walk or needing intervention to walk, the demand for a sustainable product to aid in the rehabilitation process has steadily increased. Ekso Bionics had been working to help fill this void and aid in the recovery of individuals with hemiplegia due to stroke.
Ekso Bionics has now received clearance from the U.S. Food and Drug Administration (FDA) to market its Ekso GT robotic exoskeleton, the first to be cleared by the FDA for use with stroke patients. The clearance of this product is a milestone for establishing a major standard of rehabilitation of stroke patients. Ekso GT is a wearable robotic exoskeleton that enables individuals to stand up and walk over ground with a full weight bearing. Used in a clinical setting this product could be the first of many steps in the recovery process for a stroke survivor.
The print component of “Stroke Awareness” is distributed within this Friday's edition of USA Today in New York, Los Angeles, North Central Florida, Washington D.C. and Baltimore, with a circulation of approximately 250,000 copies and an estimated readership of 750,000. The digital component is distributed through a vast social media strategy, across a system of top news sites and partner outlets.
About Ekso Bionics
Ekso Bionics is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical, industrial and defense applications. Founded in 2005, the company continues to build upon its unparalleled expertise to design some of the most cutting-edge, innovative wearable robots available on the market. They are the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe, to providing research for the advancement of R&D projects intended to benefit U.S. defense capabilities.
Mediaplanet is the leading independent publisher of content-marketing campaigns covering a variety of topics and industries. We turn consumer interest into action by providing readers with motivational editorial, pairing it with relevant advertisers and distributing it within top newspapers and online platforms around the world.